Abstract:(1) Background: Aspergillus flavus is a cosmopolitan mold with medical, veterinary, and agronomic concerns. Its morphological similarity to other cryptic species of the Flavi section requires molecular identification techniques that are not routinely performed. For clinical isolates of Aspergillus section Flavi, we present the molecular identification, susceptibility to six antifungal agents, and clinical context of source patients. (2) Methods: One hundred forty fungal clinical isolates were included in the study. These isolates, recovered over a 15-year period (2001–2015), were identified based on their morphological characteristics as belonging to section Flavi. After the subculture, sequencing of a part of the β-tubulin and calmodulin genes was performed, and resistance to azole antifungals was screened on agar plates containing itraconazole and voriconazole. Minimum inhibitory concentrations were determined for 120 isolates by the European Committee on Antimicrobial Susceptibility Testing (EUCAST) broth microdilution method. (3) Results: Partial β-tubulin and calmodulin sequences analysis showed that 138/140 isolates were A. flavus sensu stricto, 1 isolate was A. parasiticus/sojae, and 1 was A. nomiae. Many of the isolates came from samples collected in the context of respiratory tract colonization. Among probable or proven aspergillosis, respiratory infections were the most frequent, followed by ENT infections. Antifungal susceptibility testing was available for isolates (n = 120, all A. flavus ss) from one hospital. The MIC range (geometric mean MIC) in mg/L was 0.5–8 (0.77), 0.5–8 (1.03), 0.125–2 (0.25), 0.03–2 (0.22), 0.25–8 (1.91), and 0.03–0.125 (0.061) for voriconazole, isavuconazole, itraconazole, posaconazole, amphotericin B, and caspofungin, respectively. Two (1.67%) isolates showed resistance to isavuconazole according to current EUCAST breakpoints with MICs at 8 mg/L for isavuconazole and voriconazole. One of these two isolates was also resistant to itraconazole with MIC at 2 mg/L. (4) Conclusions: The present characterization of a large collection of Aspergillus belonging to the Flavi section confirmed that A. flavus ss is the predominant species. It is mainly implicated in respiratory and ENT infections. The emergence of resistance highlights the need to perform susceptibility tests on section Flavi isolates.

Expression of elastinolytic activity among isolates in Aspergillus section flavi.

Chemical Investigation of a Co-Culture of Aspergillus Fumigatus D and Fusarium Oxysporum R1

The Molecular Identification and Antifungal Susceptibility of Clinical Isolates of Aspergillus Section Flavi from Three French Hospitals

Aspergillus Proteolytic Enzymes Hydrolyzing Fibrillar Proteins for Biomedicine and Biotechnological Processes

A comparative genomics study of 23 Aspergillus species from section Flavi

Characterization of Aspergillus section Flavi associated with stored grains

Susceptibility Testing of Environmental and Clinical Aspergillus sydowii Demonstrates Potent Activity of Various Antifungals

Antifungal Activity of Essential Oil and Plant-Derived Natural Compounds against Aspergillus flavus

Genotyping and Antifungal Susceptibility Testing of Aspergillus flavus Isolated from Clinical Specimens

Antifungal compounds from Bacillus subtilis B-FS06 inhibiting the growth of Aspergillus flavus

Isolation of azole-resistant Aspergillus spp. from food products

Gelation of globular proteins.

AflaILVB/G/I and AflaILVD are involved in mycelial production, aflatoxin biosynthesis, and fungal virulence in Aspergillus flavus

A multi-aspect analysis of two analogous aspergillus spp. belonging to section Flavi: aspergillus flavus and aspergillus oryzae

Antifungal mechanisms investigation of lactic acid bacteria against Aspergillus flavus: through combining microbial metabolomics and co-culture system

Identification of B-FS06 and the Antagonistic Activity of Its Cultural Productions Against Aspergillus Flavus

Hyperexpression of Two Aspergillus Niger Xylanase Genes in Escherichia Coli and Characterization of the Gene Products

Catalytic properties of purified alpha amylase from Aspergillus flavus cultivated on low-cost agricultural substrate

Maize Aspergillus section Flavi isolate diversity may be distinct from that of soil and subsequently the source of aflatoxin contamination

Bacillus siamensis 3BS12-4 Extracellular Compounds as a Potential Biological Control Agent against Aspergillus flavus

MOLECULAR EXPRESSION PROFILE OF DIFFERENT CELLULOLYTIC ENZYME GENES IN ASPERGILLUS NIGER IN RESPONSE TO UV RADIATION AND CHEMICAL MUTAGENESIS